Novo Nordisk

News

Novo accelerates launch plans for oral semaglutide

Novo Nordisk has said it is accelerating launch preparations for its new diabetes pill semaglutide, after investing in a voucher that will allow a fast review of the drug in the US.

News

Novo begins R&D tie-up with AI biotech e-Therapeutics

Novo Nordisk has signed a deal with UK biotech e-Therapeutics to use its AI-based drug discovery technology to find new therapies for type 2 diabetes.

News

Novo Nordisk's diabetes pill clears cardiac safety hurdle

Novo Nordisk is set to file its daily semaglutide type 2 diabetes pill after it cleared a phase 3 trial assessing its cardiac safety, with results showing it also reduced risk of cardiovasc

News

Gene therapy firm BioMarin stages haemophilia musical

BioMarin Pharmaceutical has put on a stage musical to raise awareness about haemophilia, and determine whether creative expression helps patients, as it develops an experimental cure for th

News

Novo Nordisk staff cull swells to 1,300

Novo Nordisk has raised the number of staff it will shed this year in order to invest more in developing new drugs and supporting its most important products.

News

AZ to continue with investment freeze following 'no deal' Br...

AstraZeneca will keep manufacturing investments in Britain on hold if the UK’s negotiations with Brussels fail to provide clarity on future trading relations, according to press reports.

Novo accelerates launch plans for oral semaglutide

Novo begins R&D tie-up with AI biotech e-Therapeutics

Novo Nordisk's diabetes pill clears cardiac safety hurdle

Gene therapy firm BioMarin stages haemophilia musical

Novo Nordisk staff cull swells to 1,300

AZ to continue with investment freeze following 'no deal' Br...

Re-rostered FDA committee backs peptide compounding

Discover a new era of healthcare panel engagement: Grounded ...

Novo Nordisk

Editor's Picks